Emerging proteomics biomarkers and prostate cancer burden in Africa

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766 · see citing works

Global cancer statistics, 2012

Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,858 · see citing works

Tissue-based map of the human proteome

Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286 · see citing works

The cancer genome atlas pan-cancer analysis project

The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013) · Nature Genetics · doi:10.1038/ng.2764 · Cited by 9,092 · see citing works

The Molecular Taxonomy of Primary Prostate Cancer

Abeshouse, A. A., Ahn, J., Akbani, R., Ally, A., Amin, S. B., Andry, C., Annala, M., Aprikian, A. G., Armenia, J., Arora, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.10.025 · Cited by 3,081 · see citing works

The Global Burden of Cancer 2013

Fitzmaurice, C., Dicker, D., Pain, A. W., Hamavid, H., Moradi‐Lakeh, M., MacIntyre, M. F., Allen, C., Hansen, G. M., Woodbrook, R., Wolfe, C. D. A., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.0735 · Cited by 2,709 · see citing works

Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement

Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-2-201207170-00459 · Cited by 2,524 · see citing works

Phases of Biomarker Development for Early Detection of Cancer

Pepe, M. S., Etzioni, R., Feng, Z., Potter, J. D., Thompson, M. L., Thornquist, M., Winget, M., & Yasui, Y. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1054 · Cited by 1,686 · see citing works

GLOBOCAN 2008 v1.2, Cancer incidence and mortality world-wide : IARC Cancer Base No. 10

Ferlay, J. (2010) · Medical Entomology and Zoology · Cited by 1,636 · see citing works

The genomic complexity of primary human prostate cancer

Berger, M. F., Lawrence, M. S., Demichelis, F., Drier, Y., Cibulskis, K., Sivachenko, A., Sboner, A., Esgueva, R., Pflueger, D., Sougnez, C. L., et al. (2011) · Nature · doi:10.1038/nature09744 · Cited by 1,213 · see citing works

DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.

Bussemakers, M. J. G., van Bokhoven, A., Verhaegh, G. W. C. T., Smit, F. P., Karthaus, H. F. M., Schalken, J. A., Debruyne, F. M. J., Ru, N., & Isaacs, W. B. (1999) · PubMed · Cited by 1,051 · see citing works

Cancer biomarkers

Henry, N. L., & Hayes, D. F. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.01.010 · Cited by 876 · see citing works

Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy

Erho, N., Crisan, A., Vergara, I. A., Mitra, A. P., Ghadessi, M., Buerki, C., Bergstralh, E. J., Kollmeyer, T. M., Fink, S. R., Haddad, Z., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066855 · Cited by 646 · see citing works

Prostate cancer and inflammation: the evidence

Sfanos, K. S., & Marzo, A. M. D. (2011) · Histopathology · doi:10.1111/j.1365-2559.2011.04033.x · Cited by 614 · see citing works

Human body fluid proteome analysis

Hu, S., Loo, J. A., & Wong, D. T. (2006) · PROTEOMICS · doi:10.1002/pmic.200600284 · Cited by 530 · see citing works

Prostate‐specific antigen: A review of the validation of the most commonly used cancer biomarker

Hernández, J., & Thompson, I. M. (2004) · Cancer · doi:10.1002/cncr.20480 · Cited by 529 · see citing works

Proteomics: Challenges, Techniques and Possibilities to Overcome Biological Sample Complexity

Chandramouli, K., & Qian, P. (2009) · Human Genomics and Proteomics · doi:10.4061/2009/239204 · Cited by 514 · see citing works

Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement

U.S. Preventive Services Task Force* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-3-200808050-00008 · Cited by 506 · see citing works

Beyond PSA: The Next Generation of Prostate Cancer Biomarkers

Prensner, J. R., Rubin, M. A., Wei, J. T., & Chinnaiyan, A. M. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003180 · Cited by 470 · see citing works

Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations

Jemal, A., Fedewa, S. A., Ma, J., Siegel, R. L., Lin, C. C., Brawley, O. W., & Ward, E. (2015) · JAMA · doi:10.1001/jama.2015.14905 · Cited by 470 · see citing works

Cancer burden in Africa and opportunities for prevention

Jemal, A., Bray, F., Forman, D., O’Brien, M., Ferlay, J., & Parkin, D. M. (2012) · Cancer · doi:10.1002/cncr.27410 · Cited by 462 · see citing works

Urine in Clinical Proteomics

Decramer, S., de Peredo, A. G., Breuil, B., Mischak, H., Monsarrat, B., Bascands, J., & Schanstra, J. P. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r800001-mcp200 · Cited by 446 · see citing works

Discovery of Urinary Biomarkers

Pisitkun, T., Johnstone, R. M., & Knepper, M. A. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r600004-mcp200 · Cited by 403 · see citing works

The human proteome project: current state and future direction

Legrain, P., Aebersold, R., Archakov, A., Bairoch, A., Bala, K., Beretta, L., Bergeron, J., Borchers, C. H., Corthals, G. L., Costello, C. E., et al. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.009993 · Cited by 352 · see citing works

Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine

Drucker, E., & Krapfenbauer, K. (2013) · The EPMA Journal · doi:10.1186/1878-5085-4-7 · Cited by 352 · see citing works

The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: A Cohort Study and Meta-analysis

Pettersson, A., Graff, R. E., Bauer, S. R., Pitt, M. J., Lis, R. T., Stack, E. C., Martin, N. E., Kunz, L. M., Penney, K. L., Ligon, A. H., et al. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0042 · Cited by 318 · see citing works

Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers

Marrinucci, D. C., Bethel, K. J., Kolatkar, A. R., Luttgen, M. S., Malchiodi, M., Baehring, F., Voigt, K., Lazar, D. C., Nieva, J. J., Bazhenova, L. A., et al. (2012) · Physical Biology · doi:10.1088/1478-3975/9/1/016003 · Cited by 303 · see citing works

PSA and beyond: alternative prostate cancer biomarkers

Saini, S. (2016) · Cellular Oncology · doi:10.1007/s13402-016-0268-6 · Cited by 297 · see citing works

A systematic review of humoral immune responses against tumor antigens

Reuschenbach, M., Doeberitz, M. V. K., & Wentzensen, N. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-009-0733-4 · Cited by 281 · see citing works

UK Biobank: From Concept to Reality

Ollier, W., Sprosen, T., & Peakman, T. (2005) · Pharmacogenomics · doi:10.2217/14622416.6.6.639 · Cited by 278 · see citing works

Can Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer?

Wei, J. T., Feng, Z., Partin, A. W., Brown, E. C., Thompson, I. M., Sokoll, L. J., Chan, D. W., Lotan, Y., Kibel, A. S., Busby, J. E., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.8505 · Cited by 274 · see citing works

Current Status of Biomarkers for Prostate Cancer

Velonas, V., Woo, H. H., dos Remedios, C. G., & Assinder, S. J. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140611034 · Cited by 218 · see citing works

Theranostics: A treasured tailor for tomorrow

Jeelani, S., Reddy, R. J., Maheswaran, T., et al. (2014) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.137249 · Cited by 216 · see citing works

Human prostate cancer precursors and pathobiology

Marzo, A. M. D., Meeker, A. K., Zha, S., Luo, J., Nakayama, M., Platz, E. A., Isaacs, W. B., & Nelson, W. G. (2003) · Urology · doi:10.1016/j.urology.2003.09.053 · Cited by 204 · see citing works

The failure of protein cancer biomarkers to reach the clinic: why, and what can be done to address the problem?

Diamandis, E. P. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-87 · Cited by 186 · see citing works

Biomarkers in prostate cancer

Sartori, D. A., & Chan, D. W. (2014) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000065 · Cited by 172 · see citing works

Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate Cancer

Yamoah, K., Johnson, M. H., Choeurng, V., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.8912 · Cited by 144 · see citing works

Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error

Shipitsin, M. V., Small, C., Choudhury, S., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.396 · Cited by 141 · see citing works

Liquid biopsy for cancer screening, patient stratification and monitoring

Brock, G., Castellanos-Rizaldos, E., Hu, L., Coticchia, C. M., & Skog, J. (2018) · Translational Cancer Research · doi:10.21037/4546 · Cited by 131 · see citing works

Real-time liquid biopsies become a reality in cancer treatment.

Karachaliou, N., Mayo‐de‐las‐Casas, C., Molina‐Vila, M. Á., & Rosell, R. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.01.16 · Cited by 131 · see citing works

Humoral Immune Response to -Methylacyl-CoA Racemase and Prostate Cancer

Sreekumar, A., Laxman, B., Rhodes, D. R., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh145 · Cited by 130 · see citing works

Circulating tumor cells and DNA as liquid biopsies

Heitzer, E., Auer, M., Ulz, P., Geigl, J. B., & Speicher, M. R. (2013) · Genome Medicine · doi:10.1186/gm477 · Cited by 130 · see citing works

Identification of candidate prostate cancer biomarkers in prostate needle biopsy specimens using proteomic analysis

Lin, J., Xu, J., Tian, H., Gao, X., Chen, Q., Gu, Q., Xu, G., Song, J., & Zhao, F. (2007) · International Journal of Cancer · doi:10.1002/ijc.23016 · Cited by 125 · see citing works

Biomarkers in prostate cancer surveillance and screening: past, present, and future

Cary, K. C., & Cooperberg, M. R. (2013) · Therapeutic Advances in Urology · doi:10.1177/1756287213495915 · Cited by 124 · see citing works

Decreased α-Methylacyl CoA Racemase Expression in Localized Prostate Cancer is Associated with an Increased Rate of Biochemical Recurrence and Cancer-Specific Death

Rubin, M. A., Bismar, T. A., Andrén, O., et al. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0801 · Cited by 124 · see citing works

Clinical use of novel urine and blood based prostate cancer biomarkers: A review

Dijkstra, S., Mulders, P., & Schalken, J. A. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.10.023 · Cited by 122 · see citing works

Immunotherapy for Prostate Cancer: Recent Advances, Lessons Learned, and Areas for Further Research

Gulley, J. L., & Drake, C. G. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2656 · Cited by 116 · see citing works

Clinical Trial Designs for Predictive Biomarker Validation: One Size Does Not Fit All

Mandrekar, S. J., & Sargent, D. J. (2009) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543400902802458 · Cited by 113 · see citing works

Prostate Cancer Incidence Rates in Africa

Chu, L. W., Ritchey, J. D., Devesa, S. S., et al. (2011) · Prostate Cancer · doi:10.1155/2011/947870 · Cited by 113 · see citing works

Challenges in biobank governance in Sub-Saharan Africa

Staunton, C., & Moodley, K. (2013) · BMC Medical Ethics · doi:10.1186/1472-6939-14-35 · Cited by 110 · see citing works

Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach

Beretov, J., Wasinger, V. C., Millar, E. K. A., Schwartz, P. E., Graham, P., & Li, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141876 · Cited by 110 · see citing works

Tissue Proteomics Reveals Differential and Compartment-Specific Expression of the Homologs Transgelin and Transgelin-2 in Lung Adenocarcinoma and Its Stroma

Rho, J.-H., Roehrl, M. H. A., & Wang, J. Y. (2009) · Journal of Proteome Research · doi:10.1021/pr900705r · Cited by 107 · see citing works

An NCI Perspective on Creating Sustainable Biospecimen Resources

Vaught, J., Rogers, J., Myers, K., Lim, M. D., Lockhart, N. C., Moore, H. A., Sawyer, S. J., Furman, J. L., & Compton, C. C. (2011) · JNCI Monographs · doi:10.1093/jncimonographs/lgr006 · Cited by 106 · see citing works

Antibody validation of immunohistochemistry for biomarker discovery: Recommendations of a consortium of academic and pharmaceutical based histopathology researchers

Howat, W., Lewis, A. R., Jones, P., Kampf, C., Pontén, F., van der Loos, C. M., Gray, N. M., Womack, C., & Warford, A. (2014) · Methods · doi:10.1016/j.ymeth.2014.01.018 · Cited by 104 · see citing works

A Pathway and Approach to Biomarker Validation and Qualification for Osteoarthritis Clinical Trials

Hunter, D. J., Losina, E., Guermazi, A., Burstein, D., Lassere, M. N., & Kraus, V. B. (2010) · Current Drug Targets · doi:10.2174/138945010791011947 · Cited by 100 · see citing works

Prostate Cancer Progression Correlates with Increased Humoral Immune Response to a Human Endogenous Retrovirus GAG Protein

Reis, B. S., Jungbluth, A. A., Frosina, D., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3580 · Cited by 99 · see citing works

Molecular Theranostics: A Primer for the Imaging Professional

Lee, D. Y., & Li, K. C. P. (2011) · American Journal of Roentgenology · doi:10.2214/ajr.11.6797 · Cited by 95 · see citing works

The Present and Future of Biomarkers in Prostate Cancer: Proteomics, Genomics, and Immunology Advancements

Gaudreau, P.-O., Stagg, J., Soulières, D., & Fred Saad, C. (2016) · Biomarkers in Cancer · doi:10.4137/bic.s31802 · Cited by 95 · see citing works

Abnormal blood biomarkers in early pregnancy are associated with preeclampsia: a meta-analysis

Allen, R. E., Rogozińska, E., Cleverly, K., Aquilina, J. T., & Thangaratinam, S. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.09.027 · Cited by 93 · see citing works

Validation and clinical utility of prostate cancer biomarkers

Scher, H. I., Morris, M. J., Larson, S. M., & Heller, G. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.30 · Cited by 92 · see citing works

Durable Carcinoembryonic Antigen (CEA)-Specific Humoral and Cellular Immune Responses in Colorectal Carcinoma Patients Vaccinated with Recombinant CEA and Granulocyte/Macrophage Colony-Stimulating Factor

Ullenhag, G. J., Frödin, J., Jeddi‐Tehrani, M., Strigård, K., Eriksson, E., Samanci, A., Choudhury, A., Nilsson, B., Rossmann, E. D., Mosolits, S., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0706 · Cited by 92 · see citing works

Genotyping cell-free tumor DNA in the blood to detect residual disease and drug resistance

Siravegna, G., & Bardelli, A. (2014) · Genome biology · doi:10.1186/s13059-014-0449-4 · Cited by 88 · see citing works

Sexually Transmissible Infections and Prostate Cancer Risk

Huang, W., Hayes, R. B., Pfeiffer, R. M., et al. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0173 · Cited by 88 · see citing works

Building capacity for sustainable research programmes for cancer in Africa

Adewole, I. F., Martin, D. N., Williams, M. J., et al. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.37 · Cited by 78 · see citing works

NY‐ESO‐1 protein expression and humoral immune responses in prostate cancer

Fosså, A., Berner, A., Fosså, S. D., et al. (2004) · The Prostate · doi:10.1002/pros.20025 · Cited by 76 · see citing works

Prostatic acid phosphatase expression in human tissues.

Graddis, T. J., McMahan, C. J., Tamman, J., et al. (2011) · PubMed · Cited by 75 · see citing works

Tumour markers in prostate cancer III: Biomarkers in urine

Roobol, M. J., Haese, A., & Bjartell, A. S. (2011) · Acta Oncologica · doi:10.3109/0284186x.2010.524935 · Cited by 75 · see citing works

Analytic and Clinical Validation of a Prostate Cancer–Enhanced Messenger RNA Detection Assay in Whole Blood as a Prognostic Biomarker for Survival

Danila, D. C., Anand, A., Schultz, N. D., Heller, G., Wan, M., Sung, C. C., Dai, C. S., Khanin, R., Fleisher, M., Lilja, H. G., et al. (2013) · European Urology · doi:10.1016/j.eururo.2013.07.006 · Cited by 74 · see citing works

Cancer vaccines 2004 opening address: the molecular and cellular basis of cancer immunosurveillance and immunoediting.

Todorova, K. O., Ignatova, I., Tchakarov, S., Altankova, I., Zoubak, S., Kyurkchiev, S., & Mincheff, M. S. (2005) · PubMed · Cited by 74 · see citing works

The role of proteomics in prostate cancer research: Biomarker discovery and validation

Pin, E., Fredolini, C., & Petricoin, E. F. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.12.012 · Cited by 71 · see citing works

Proteomic Profiling of Serum-Derived Exosomes from Ethnically Diverse Prostate Cancer Patients

Turay, D., Khan, S., Osterman, C. J. D., Curtis, M. P., Khaira, B., Neidigh, J. W., Mirshahidi, S., Casiano, C. A., & Wall, N. R. (2015) · Cancer Investigation · doi:10.3109/07357907.2015.1081921 · Cited by 71 · see citing works

Proteomics analysis of urine reveals acute phase response proteins as candidate diagnostic biomarkers for prostate cancer

Davalieva, K., Kiprijanovska, S., Komina, S., Petruševska, G., Zografska, N. C., & Polenakovic, M. H. (2015) · Proteome Science · doi:10.1186/s12953-014-0059-9 · Cited by 66 · see citing works

Comparative Tissue Proteomics of Microdissected Specimens Reveals Novel Candidate Biomarkers of Bladder Cancer

Chen, C., Chung, T., Wu, C., Ng, K., Yu, J., Tsai, C.-H., Chang, Y., Liang, Y. J., Tsui, K., & Chen, Y. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.051524 · Cited by 64 · see citing works

Biomarkers for Alzheimer's disease in plasma, serum and blood - conceptual and practical problems

Galasko, D. R., & Golde, T. E. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt164 · Cited by 64 · see citing works

Circulating Tumor Cells in Prostate Cancer Diagnosis and Monitoring: An Appraisal of Clinical Potential

Galletti, G., Portella, L., Tagawa, S. T., Kirby, B. J., Giannakakou, P., & Nanus, D. M. (2014) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-014-0101-8 · Cited by 61 · see citing works

Genetic tests and genomic biomarkers: regulation, qualification and validation.

Novelli, G., Ciccacci, C., Borgiani, P., Amati, M. P., & Abadie, E. (2008) · PubMed Central · Cited by 61 · see citing works

Tumour markers in prostate cancer II: Diagnostic and prognostic cellular biomarkers

Bjartell, A. S., Montironi, R., Berney, D. M., & Egevad, L. (2011) · Acta Oncologica · doi:10.3109/0284186x.2010.531284 · Cited by 59 · see citing works

Incorporation of tissue-based genomic biomarkers into localized prostate cancer clinics

Moschini, M., Spahn, M., Mattei, A., Cheville, J. C., & Karnes, R. J. (2016) · BMC Medicine · doi:10.1186/s12916-016-0613-7 · Cited by 59 · see citing works

Validation of proposed prostate cancer biomarkers with gene expression data: a long road to travel

Amaro, A. A., Esposito, A. I., Gallina, A. M., Nees, M., Angelini, G., Albini, A., & Pfeffer, U. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9470-4 · Cited by 58 · see citing works

Induction of Specific Cellular and Humoral Responses Against Renal Cell Carcinoma After Combination Therapy With Cryoablation and Granulocyte-Macrophage Colony Stimulating Factor

Thakur, A. B., Littrup, P. J., Paul, E. N., et al. (2011) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31821dcba5 · Cited by 58 · see citing works

The human proteome project: Current state and future direction

Legrain, P., Aebersold, R. H., Archakov, A. I., Bairoch, A., Bala, K., Beretta, L., Bergeron, J. J. M., Borchers, C. H., Corthals, G. L., Costello, C. E., et al. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o111.009993 · Cited by 58 · see citing works

Cancer registries in Africa 2014: A survey of operational features and uses in cancer control planning

Gakunga, R., Parkin, D. M., & On behalf of the African Cancer Registry Network (2015) · International Journal of Cancer · doi:10.1002/ijc.29668 · Cited by 57 · see citing works

Challenges of Biobanking in South Africa to Facilitate Indigenous Research in an Environment Burdened with Human Immunodeficiency Virus, Tuberculosis, and Emerging Noncommunicable Diseases

Abayomi, A., Christoffels, A. G., Grewal, R., et al. (2013) · Biopreservation and Biobanking · doi:10.1089/bio.2013.0049 · Cited by 56 · see citing works

Proteomic Approaches in Biomarker Discovery: New Perspectives in Cancer Diagnostics

Hudler, P., Britovšek, N. K., & Komel, R. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/260348 · Cited by 55 · see citing works

Evaluation of protein biomarkers of prostate cancer aggressiveness

Rizzardi, A. E., Rosener, N. K., Koopmeiners, J. S., Vogel, R. I., Metzger, G. J., Forster, C. L., Marston, L. O., Tiffany, J. R., McCarthy, J. B., Turley, E. A., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-244 · Cited by 55 · see citing works

Prostate cancer markers: An update

Pentyala, S., Whyard, T. C., Pentyala, S., Müller, J., Pfail, J. L., Parmar, S., Helguero, C. G., & Khan, S. (2016) · Biomedical Reports · doi:10.3892/br.2016.586 · Cited by 55 · see citing works

Identification and Validation of Potential New Biomarkers for Prostate Cancer Diagnosis and Prognosis Using 2D-DIGE and MS

Geisler, C., Gaisa, N. T., Pfister, D. J. K. P., Fuessel, S., Kristiansen, G., Braunschweig, T. A., Gostek, S., Beine, B., Diehl, H. C., Jackson, A., et al. (2015) · BioMed Research International · doi:10.1155/2015/454256 · Cited by 52 · see citing works

Biospecimens and Biorepositories: From Afterthought to Science

Vaught, J. B., Henderson, M. K., & Compton, C. C. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-1179 · Cited by 51 · see citing works

Biomarkers for Cancer Risk, Early Detection, and Prognosis: The Validation Conundrum

Brenner, D. E., & Normolle, D. P. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2619 · Cited by 51 · see citing works

Prostatic acid phosphatase expression in human tissues

Graddis, T. J., McMahan, C. J., Tamman, J., et al. (2010) · Clinical Cancer Research · doi:10.1158/diag-10-b29 · Cited by 51 · see citing works

Proteomics for the identification of new prostate cancer biomarkers

Ornstein, D. K., & Tyson, D. R. (2006) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2005.11.035 · Cited by 50 · see citing works

Genetic susceptibility to prostate cancer in men of African descent: implications for global disparities in incidence and outcomes.

Zeigler-Johnson, C. M., Spangler, E., Jalloh, M., Gueye, S. M., Rennert, H., & Rebbeck, T. R. (2008) · PubMed · Cited by 49 · see citing works

Theranostic and prognostic biomarkers: genomic applications in urological malignancies

Netto, G. J., & Epstein, J. I. (2010) · Pathology · doi:10.3109/00313021003779145 · Cited by 49 · see citing works

Evolving Role of Bone Biomarkers in Castration-Resistant Prostate Cancer

Brown, J. E., & Sim, S. (2010) · Neoplasia · doi:10.1593/neo.10610 · Cited by 48 · see citing works

Mass spectrometry‐based clinical proteomics: Head‐and‐neck cancer biomarkers and drug‐targets discovery

Matta, A., Ralhan, R., DeSouza, L. V., & Siu, K. W. M. (2010) · Mass Spectrometry Reviews · doi:10.1002/mas.20296 · Cited by 48 · see citing works

Novel potential serological prostate cancer biomarkers using CT100+ cancer antigen microarray platform in a multi-cultural South African cohort

Adeola, H. A., Smith, M., Kaestner, L., Blackburn, J. M., & Zerbini, L. F. (2016) · Oncotarget · doi:10.18632/oncotarget.7359 · Cited by 48 · see citing works

Genetic analysis of the principal genes related to prostate cancer: A review

Álvarez-Cubero, M. J., Saiz, M., Martínez-González, L. J., et al. (2012) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2012.07.011 · Cited by 45 · see citing works

NIH State-of-the-Science Conference Statement: Role of active surveillance in the management of men with localized prostate cancer.

Ganz, P., Barry, J. M., Burke, W., et al. (2013) · PubMed · Cited by 43 · see citing works

Do serum biomarkers really measure breast cancer?

Jesneck, J. L., Mukherjee, S., Yurkovetsky, Z. R., Clyde, M. A., Marks, J. R., Lokshin, A. E., & Lo, J. Y.-C. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-164 · Cited by 42 · see citing works

Prostate cancer health and cultural beliefs of black men: The Florida Prostate Cancer Disparity Project

Odedina, F. T., Dagne, G. A., Pressey, S., Odedina, O., Emanuel, F. S., Scrivens, J. J., Reams, R., Adams, A., & Larose-Pierre, M. (2011) · Infectious Agents and Cancer · doi:10.1186/1750-9378-6-s2-s10 · Cited by 42 · see citing works

Use of human specimens in research: the evolving United States regulatory, policy, and scientific landscape

Bledsoe, M. J., & Grizzle, W. E. (2013) · Diagnostic Histopathology · doi:10.1016/j.mpdhp.2013.06.015 · Cited by 39 · cited 1× · see citing works

Real-time liquid biopsy: circulating tumor cells versus circulating tumor DNA.

Alix‐Panabières, C., & Pantel, K. (2013) · PubMed Central · doi:10.3978/j.issn.2305-5839.2013.06.02 · Cited by 37 · see citing works

Application of proteomic strategies to the identification of urinary biomarkers for prostate cancer: A review

Downes, M. R., Byrne, J. C., Dunn, M. J., Fitzpatrick, J. M., Watson, R. W. G., & Pennington, S. R. (2006) · Biomarkers · doi:10.1080/13547500600799821 · Cited by 32 · see citing works

Management of advanced prostate cancer in Africa.

Olapade-Olaopa, E. O., Obamuyide, H. A., & Yisa, G. T. (2008) · PubMed · Cited by 29 · see citing works

Predominance of ERG-negative high-grade prostate cancers in African American men

Farrell, J. S., Young, D., Chen, Y., et al. (2014) · Molecular and Clinical Oncology · doi:10.3892/mco.2014.378 · Cited by 29 · see citing works

An Integrative Proteomics and Interaction Network-Based Classifier for Prostate Cancer Diagnosis

Jiang, F., He, H., Zhang, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063941 · Cited by 29 · see citing works

Discovery of serum protein biomarkers for prostate cancer progression by proteomic analysis.

Alruwaili, J., Larkin, S. E. T., Zeidan, B. A., et al. (2010) · PubMed · Cited by 29 · see citing works

Tissue proteomics using chemical immobilization and mass spectrometry

Shah, P., Zhang, B., Choi, C. H., et al. (2014) · Analytical Biochemistry · doi:10.1016/j.ab.2014.09.017 · Cited by 28 · see citing works

Prognostic role of genetic biomarkers in clinical progression of prostate cancer

Álvarez-Cubero, M. J., Martínez-González, L. J., Saiz, M., et al. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2015.43 · Cited by 27 · see citing works

Proteomics in prostate cancer

Bañez, L. L., Srivastava, S. K., & Moul, J. W. (2005) · Current Opinion in Urology · doi:10.1097/01.mou.0000165547.48922.12 · Cited by 27 · see citing works

Seizing the opportunity to close the cancer divide

Knaul, F. M., Atun, R. A., Farmer, P., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60176-2 · Cited by 27 · see citing works

A guide for clinicians in the evaluation of emerging molecular diagnostics for newly diagnosed prostate cancer.

Canfield, S. E., Kibel, A. S., Kemeter, M. J., Febbo, P. G., Lawrence, H. J., & Moul, J. W. (2014) · PubMed Central · Cited by 27 · see citing works

In 2124, Half of All Men Can Count on Developing Prostate Cancer

Pollock, P., Ludgate, A., & Wassersug, R. J. (2015) · Current Oncology · doi:10.3747/co.22.2102 · Cited by 26 · see citing works

High alpha-methylacyl-CoA racemase (AMACR) is associated with ERG expression and with adverse clinical outcome in patients with localized prostate cancer

Box, A. H., Alshalalfa, M., Hegazy, S. A., et al. (2016) · Tumor Biology · doi:10.1007/s13277-016-5075-1 · Cited by 25 · see citing works

Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy

Fredolini, C., Liotta, L. A., & Petricoin, E. F. (2010) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2010.503558 · Cited by 24 · see citing works

Integrative analysis reveals disease-associated genes and biomarkers for prostate cancer progression

Li, Y., Vongsangnak, W., Chen, L., & Shen, B. (2014) · BMC Medical Genomics · doi:10.1186/1755-8794-7-s1-s3 · Cited by 24 · see citing works

Discovery of novel candidate urinary protein biomarkers for prostate cancer in a multiethnic cohort of South African patients via label‐free mass spectrometry

Adeola, H. A., Soares, N. C., Paccez, J. D., Kaestner, L., Blackburn, J. M., & Zerbini, L. F. (2015) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201400197 · Cited by 23 · see citing works

The feasibility of epidemiological research on prostate cancer in African men in Ibadan, Nigeria

Agalliu, I., Adebiyi, A., Lounsbury, D. W., et al. (2015) · BMC Public Health · doi:10.1186/s12889-015-1754-x · Cited by 22 · see citing works

Proteomics in prostate cancer biomarker discovery

Larkin, S. E. T., Zeidan, B. A., Taylor, M. G., et al. (2010) · Expert Review of Proteomics · doi:10.1586/epr.09.89 · Cited by 21 · see citing works

Liquid biopsy in gastrointestinal stromal tumors: a novel approach

Nannini, M., Astolfi, A., Urbini, M., et al. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-210 · Cited by 20 · see citing works

Biobank Classification in an Australian Setting

Rush, A., Christiansen, J. H., Farrell, J. P., Goode, S. M., Scott, R. J., Spring, K. J., & Byrne, J. A. (2015) · Biopreservation and Biobanking · doi:10.1089/bio.2015.0007 · Cited by 16 · see citing works

A perpetual source of DNA or something really different: ethical issues in the creation of cell lines for African genomics research

de Vries, J., Abayomi, A., Brandful, J., et al. (2014) · BMC Medical Ethics · doi:10.1186/1472-6939-15-60 · Cited by 16 · see citing works

In Silico Verification and Parallel Reaction Monitoring Prevalidation of Potential Prostate Cancer Biomarkers

Adeola, H. A., Calder, B., Soares, N. C., Kaestner, L., Blackburn, J. M., & Zerbini, L. F. (2015) · Future Oncology · doi:10.2217/fon.15.296 · Cited by 15 · see citing works

Auto-antibodies in prostate cancer: Humoral immune response to antigenic determinants coded by the differentially expressed transcripts FLJ23438 and VAMP3

Pontes, E. R. J. C., Matos, L. C., da Silva, E. A., et al. (2006) · The Prostate · doi:10.1002/pros.20439 · Cited by 14 · see citing works

Validation of surrogate endpoint biomarkers in prostate cancer chemoprevention trials

Trock, B. J. (2001) · Urology · doi:10.1016/s0090-4295(00)00983-3 · Cited by 12 · see citing works

Proteomics in diagnosis of prostate cancer.

Davalieva, K., & Polenakovic, M. H. (2015) · PubMed · Cited by 12 · see citing works

PSA and beyond: Biomarkers in prostate cancer

Huang, J. G., Campbell, N. A., & Goldenberg, S. L. (2014) · British Columbia medical journal · Cited by 10 · see citing works

Urine Proteomic Analysis: Use of Two-Dimensional Gel Electrophoresis, Isotope Coded Affinity Tags, and Capillary Electrophoresis

Sobhani, K. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-711-2_18 · Cited by 9 · see citing works

From Gene to Clinic: TMA-Based Clinical Validation of Molecular Markers in Prostate Cancer

Schlomm, T., Chun, F. K. ‐., & Erbersdobler, A. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-806-5_17 · Cited by 9 · see citing works

Integrative Genomic Analysis for the Discovery of Biomarkers in Prostate Cancer

Hicks, C., Koganti, T., Giri, S. P. G., Tekere, M., Ramani, R., Sitthi-Amorn, A., & Vijayakumar, S. (2014) · Biomarker Insights · doi:10.4137/bmi.s13729 · Cited by 8 · see citing works

Abnormal humoral immune response to mucosal antigenic stimulation in patients with lung cancer

Michils, A., Yernault, J. C., Noel, E., Gossart, B., Servais, G., & Duchateau, J. (1992) · Cancer · doi:10.1002/1097-0142(19920501)69:9 · Cited by 8 · see citing works

Sub-Saharan centralized biorepository for genetic and genomic research

Gasmelseed, N., Elsir, A. A., DeBlasio, P., & Biunno, I. (2011) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2010.07.054 · Cited by 8 · see citing works

Dataset for the quantitative proteomics analysis of the primary hepatocellular carcinoma with single and multiple lesions

Xing, X., Huang, Y., Wang, S., et al. (2015) · Data in Brief · doi:10.1016/j.dib.2015.08.036 · Cited by 8 · see citing works

Bridging the urological divide

Roberts, R. A. (2011) · Infectious Agents and Cancer · doi:10.1186/1750-9378-6-s2-s4 · Cited by 6 · see citing works

Human genome project.

Shapiro, L. J. (1993) · PubMed · Cited by 4 · see citing works

The Chromosome‐centric Human Proteome Project at FEBS Congress

Ponomarenko, E. A., Baranova, A. V., Lisitsa, A., et al. (2013) · PROTEOMICS · doi:10.1002/pmic.201300373 · Cited by 3 · see citing works

Blood Serum Biomarkers for Differential Diagnosis of Parkinson’s Disease

Goldknopf, I. L., Sheta, E. A., Bryson, J., et al. (2006) · The FASEB Journal · doi:10.1096/fasebj.20.4.a64-b · Cited by 1 · see citing works

Prostate cancer

Moul, J. W. (2005) · Current Opinion in Urology · doi:10.1097/01.mou.0000165546.48922.5b · Cited by 1 · see citing works

The dentist-scientist career pathway in Africa: opportunities and obstacles

Adeola, H. A., Adefuye, A., Soyele, O., & Butali, A. (2018) · Korean Journal of Medical Education · doi:10.3946/kjme.2018.93 · Cited by 9 · see citing works

The Challenges in Blood Proteomic Biomarker Discovery

Jin, G., Zhou, X., Wang, H., et al. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0811-7_12 · Cited by 6 · see citing works

Biomarker discovery: Study design and execution

Issaq, H. J., & Veenstra, T. D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-818607-7.00001-3 · Cited by 7 · see citing works

Biomarker Discovery

Issaq, H. J., & Veenstra, T. D. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394446-7.00001-7 · Cited by 7 · see citing works

Chapter 1 – Biomarker Discovery: Study Design and Execution

Issaq, H. J., & Veenstra, T. D. (2013) · Cited by 1 · see citing works

Mass spectrometry-based proteomics and peptidomics for biomarker discovery in neurodegenerative diseases.

Wei, X. L., & Li, L. (2009) · PubMed Central · Cited by 30 · see citing works